Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct 5:7:172.
doi: 10.3389/fneur.2016.00172. eCollection 2016.

Functional, Structural, and Neurotoxicity Biomarkers in Integrative Assessment of Concussions

Svetlana A Dambinova  1 , Joseph C Maroon  2 , Alicia M Sufrinko  3 , John David Mullins  4 , Eugenia V Alexandrova  5 , Alexander A Potapov  5
Affiliations

Functional, Structural, and Neurotoxicity Biomarkers in Integrative Assessment of Concussions

Svetlana A Dambinova et al. Front Neurol. .

Abstract

Concussion is a complex, heterogeneous process affecting the brain. Accurate assessment and diagnosis and appropriate management of concussion are essential to ensure that athletes do not prematurely return to play or others to work or active military duty, risking re-injury. To date, clinical diagnosis relies primarily on evaluating subjects for functional impairment using instruments that include neurocognitive testing, subjective symptom report, and neurobehavioral assessments, such as balance and vestibular-ocular reflex testing. Structural biomarkers, defined as advanced neuroimaging techniques and biomarkers assessing neurotoxicity and immunoexcitotoxicity, may complement the use of functional biomarkers. We hypothesize that neurotoxicity AMPA, NMDA, and kainite receptor biomarkers might be utilized as a part of comprehensive approach to concussion evaluations, with the goal of increasing diagnostic accuracy and facilitating treatment planning and prognostic assessment.

Keywords: advanced MRI sequences; concussion; mild TBI; neuropsychological evaluations; neurotoxicity and neuroplasticity biomarkers.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Collins MW, Kontos AP, Reynolds E, Murawski CD, Fu FH. A comprehensive, targeted approach to the clinical care of athletes following sport-related concussion. Knee Surg Sports Traumatol Arthrosc (2014) 22:235–46.10.1007/s00167-013-2791-6 - DOI - PubMed
    1. Dambinova SA, Sowell RL, Maroon J. Gradual return to play: potential role of neurotoxicity biomarkers in assessment of concussions severity. J Mol Biomark Diagn (2013) 3(Suppl1):S003.10.4172/2155-9929.S3-003 - DOI
    1. Lebrun CM, Mrazik M, Prasad AS, Tjarks BJ, Dorman JC, Bergeron MF, et al. Sport concussion knowledge base, clinical practises and needs for continuing medical education: a survey of family physicians and cross-border comparison. Br J Sports Med (2012) 47:54–9.10.1136/bjsports-2012-091480 - DOI - PubMed
    1. Zehtabchi S, Sinert R, Soghoian S, Liu Y, Carmody K, Shah L, et al. Identifying traumatic brain injury in patients with isolated head trauma: are arterial lactate and base deficit as helpful as in polytrauma? Emerg Med J (2007) 24:333–5.10.1136/emj.2006.044578 - DOI - PMC - PubMed
    1. Dambinova SA, Bettermann K, Glynn T, Tews M, Olson D, Weissman JD, et al. Diagnostic potential of the NMDA receptor peptide assay for acute ischemic stroke. PLoS One (2012) 7:e42362.10.1371/journal.pone.0042362 - DOI - PMC - PubMed

LinkOut - more resources